Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 51–100 of 388 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05654194	Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML	completed	Phase 3	60	The First Affiliated Hospital of Soochow UniversityOTHER	1	Jun 18, 2026	clinicaltrials
NCT07651163	Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy	enrolling by invitation	Phase 2 / Phase 3	450	First Affiliated Hospital of Zhejiang UniversityOTHER	1